9 GERIATRIC GYNECOLOGY

[Pages:10]9

GERIATRIC GYNECOLOGY

Karen L. Miller, MD; Morton A. Stenchever, MD; Holly E. Richter, PhD, MD; Evelyn C. Granieri, MD, MPH, MSEd;

William C. Andrews, MD, FACOG, FRCOG*

Gynecologists play three roles in the health care of women aged 65 and over: surgeon, consultant and therapist for gynecologic disorders, and provider of primary and preventive health care. The research reviewed here addresses topics related to one or more of these roles. Our review indicates that, as the population ages, our astounding lack of knowledge about caring for elderly women in these three contexts must be addressed.

METHODS

The MEDLINE database was searched via PubMed. The period covered was from 1990 to March 21, 2001. The search was limited to English language and human subjects. The search strategy combined the MeSH terms for gynecologic surgical procedures, hormone replacement therapy, cervical cancer and cervical cancer screening, breast cancer and breast cancer screening, ovarian cancers and ovarian cancer screening, pelvic organ prolapse, and postmenopausal osteoporosis with terms for age factors, risk factors, perioperative care, perioperative complications (including the specific terms delirium, decubitus ulcer, pneumonia, and cerebrovascular accident), comorbidity, outcome, quality of life, prognosis, recovery, length of stay, functional status, resuscitation status, and discharge planning. In all, 9522 items were retrieved.

The search was then narrowed to 1638 by requiring that the term age factors or variants of the word age be included in the title. During the time from March 2001 until this monograph was completed, striking studies from the Women's Health Initiative with unexpected results were published about hormone replacement therapy. Therefore, sections about hormone replacement were updated to include the more recent information.

PERIOPERATIVE MANAGEMENT FOR GYNECOLOGIC SURGERY

Topics and research questions regarding general perioperative management of elderly patients are addressed in the chapter on cross-cutting issues (see Chapter 13). For this chapter, studies focused on gynecologic surgery were sought to determine the current state of knowledge and to identify gaps that suggest the best direction of future research.

* Miller: Assistant Professor, Department of Obstetrics and Gynecology, University of Utah Health Sciences Center, Salt Lake City, UT; Stenchever: Professor and Chairman Emeritus, Department of Obstetrics and Gynecology, University of Washington School of Medicine, Seattle, WA; Richter: Associate Professor, Medical Surgical Gynecology, University of Alabama at Birmingham, Birmingham, AL; Granieri: Associate Professor of Geriatric Medicine, Mount Sinai School of Medicine, Chief of Geriatrics Services, Bronx VA Medical Center, Bronx, NY; Andrews: Professor Emeritus of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, VA.

225

226

CHAPTER 9

QUALITY OF DATA

Few studies have been published about gynecologic surgery in elderly women. In the published studies, many common geriatric complications were not recognized or sought by the investigators. For instance, none of the case series, retrospective reviews, or case-control studies noted delirium, falls, or electrolyte imbalance. These occur commonly in hospitalized elderly patients, and it is unlikely that they were completely absent in the populations described. Furthermore, all studies on the topic of gynecologic surgery generally were retrospective chart reviews, and undoubtedly geriatric complications were not well documented and therefore were not obtainable. Finally, no studies that evaluated functional or quality-of-life outcomes in older women were found.

Studies were found regarding the incidence and prevalence in older populations of hysterectomy, 1?3 the prevalence in older women of surgery for pelvic organ prolapse (POP), 4 complications in elderly women of gynecologic surgery (including benign and malignant diseases), 5?11 and preoperative evaluation of risk factors for cardiac complications in older women. 12 No studies involved institutionalized elderly persons.

RESULTS

Epidemiology

Annually from 1988 to 1990, 4 per 1000 women aged 65 to 74 and 2 per 1000 aged 75 and over underwent hysterectomy in the United States; 2 similar rates were reported in Finland. 9 In one state, the cumulative probability of a woman's having undergone a hysterectomy was 33% by age 55 and 43% by age 85. 1 Most hysterectomies in older women were found to have been done for POP, followed by malignant disease; roughly one third of all hysterectomies fell in each category. 1,2 Bilateral salpingo-oophorectomy was performed in 87% of abdominal and 7% of vaginal hysterectomies. 2 A woman has a 10% to 11% cumulative risk to age 80 of undergoing surgery for urinary incontinence or POP. 4,13

Morbidity and Mortality

In Finland, age was associated with mortality in 300,000 hysterectomies, not controlling for comorbidities. 9 Six-week mortality ranged from 3 per 10,000 in the age group 40 to 50 years to 209 per 10,000 in those aged 80 and over. Sixty-three percent of deaths were due primarily to cancer, and 27% to cardiovascular events. In 66,478 Medicare patients undergoing continence procedures, the 30-day mortality was 0.33%. 5 Mortality increased linearly with age, from 0.2% at age 65 to 74 to 1.6% in those aged 85 and over. Age-specific mortality rates were not adjusted for comorbid conditions. Groups of patients who died had higher rates of diabetes mellitus and heart failure. Age was not found to be associated with morbidity and mortality in other studies of gynecologic surgery, 11 POP surgery, 7 and gynecologic oncologic surgery. 10 The only prospective morbidity study included all major noncardiac surgical procedures in women aged 50 or over. 8 This study found age to be significantly associated with a greater incidence of cardiogenic pulmonary edema, myocardial infarction, ventricular arrhythmia, bacterial pneumonia, respiratory failure, and in-hospital mortality. Older patients were not found to be more likely than younger ones to experience neuropathy after dorsal lithotomy positioning. 6 A retrospec-

GERIATRIC GYNECOLOGY

227

tive review of postoperative fever evaluations found that older age increases the likelihood that the chest x-ray would "be positive" (definition not given). 14

In a retrospective analysis of 406 women undergoing elective vaginal surgery, cardiac morbidity was found to have occurred only among postmenopausal women. 12 The four congestive heart failures, one unstable angina, one unstable arrhythmia, and two deaths (apparently secondary to myocardial infarction) were not predicted by either the Goldman Cardiac Risk Index or the New York Heart Association functional classification of heart disease. Only hypertension and ischemic heart disease were found to be risk factors.

SUMMARY

Few studies have examined outcomes of gynecologic surgery in elderly women, and these have not evaluated typical geriatric complications. No studies have evaluated functional outcomes, and few have evaluated intermediate- or long-term quality-of-life changes. Mortality risks with gynecologic surgery are low and most commonly are due to cardiac or cancer complications.

Gyn 1 (Level B): Prospective observational studies should be undertaken to discover the magnitude and severity of common geriatric perioperative complications of gynecologic surgery, eg, delirium, electrolyte imbalance, falls, deconditioning, urinary incontinence, functional loss, and discharge to rehabilitation or long-term-care facilities.

Gyn 2 (Level B): Observational studies are needed to establish the risk factors for geriatric perioperative complications of gynecologic surgery, eg, delirium, electrolyte imbalance, falls, deconditioning, urinary incontinence, functional loss, and discharge to rehabilitation or long-term-care facilities.

Gyn 3 (Level B): All gynecologic surgery studies that evaluate or describe outcomes, morbidity, or mortality should describe comorbidities, functional status, cognitive status, and estrogen status of elderly women participants.

Gyn 4 (Level B): The results from existing and future gynecologic surgery studies should be stratified by age, even when statistical power is low, to facilitate systematic reviews of gynecologic surgery outcomes.

Gyn 5 (Level B): Prospective observational studies are needed to compare the quality-of-life and functional outcomes of surgical and nonsurgical management of gynecologic conditions.

Gyn 6 (Level A): Randomized controlled trials are needed to determine which interventions in elderly women are effective in reducing geriatric surgical risks, eg, delirium, electrolyte imbalance, falls, deconditioning, urinary incontinence, functional loss, and discharge to rehabilitation or long-term-care facilities.

228

CHAPTER 9

Gyn 7 (Level A): Randomized controlled trials are needed to determine whether pre- and postoperative local estrogen therapy improves surgical outcomes in a variety of gynecologic conditions.

Gyn 8 (Level A): Randomized controlled trials are needed to determine whether discontinuation of estrogen replacement therapy improves perioperative morbidity in elderly women.

Gyn 9 (Level D): Observational studies are needed to compare quality-of-life outcomes of different surgical techniques for gynecologic conditions, eg, urinary incontinence and pelvic organ prolapse.

Gyn 10 (Level D): Observational studies should be performed to determine patient and condition characteristics that are associated with improvement in quality of life after surgical treatment.

Gyn 11 (Level D): Guidelines for selecting candidates for gynecologic surgery from among older institutionalized populations on the basis of quality-of-life benefits should be prepared and validated.

Gyn 12 (Level D): As medical care changes and improves, descriptive observational studies should be performed to compare the risks of gynecologic surgery that are associated with age alone and those that are associated with comorbidities.

UROGENITAL HEALTH

Gynecologists treat both anatomic and functional aspects of urogenital health and health maintenance. Certain well-known age-related changes are secondary to estrogen deficiency and are easily treated with estrogen replacement. However, age-related functional changes are heterogeneous, and many questions remain about their causes and therapy. We address the research in POP, vulvovaginal conditions, urinary incontinence, and sexual health.

PELVIC ORGAN PROLAPSE

The surgical and nonsurgical management of POP together constitute a substantial portion of gynecologic care for older women. The exact prevalence and natural history of POP are unknown. It is the most common reason for gynecologic surgery in women aged 65 and over. Surgical repair usually consists of full vaginal reconstruction. However, vaginal obliteration with the Le Fort colpocleisis is still a useful alternative to major surgery for some frail elderly women. There is also a resurgence in conservative therapy using pessaries, as the older population grows and the imperfection of long-term surgical results becomes more evident.

Quality of Data

Epidemiology. Data regarding the prevalence of POP requiring surgery are included in the section, above, on gynecologic surgery. Prevalence data for POP apart from surgical correction are few. One descriptive study using routine gynecologic care patients included 66

GERIATRIC GYNECOLOGY

229

women aged 60 to 82. 15 One paper retrospectively reviewed admissions to a long-termcare facility. 16 Risk factors for POP that requires surgery were evaluated in a case-control study; 17 the risk factors for symptomatic pelvic floor dysfunction (including POP) were evaluated in a study using population-based cross-sectional interview data; 13 and risk factors for urinary incontinence or POP that requires surgery were assessed through a Kaiser Permanente database review. 4

Complications. Hydronephrosis as a complication of POP has been reported in two retrospective case series. 18,19 No studies were found about other well-known complications, abrasions, or urinary retention due to a large cystocele.

Nonsurgical Management. We found no data on the natural history of POP. Articles about pessaries are based mostly on expert opinion, and some are case reports. One retrospective chart review reported indications, continuation, and complications. 20

Surgical Management. A retrospective chart review evaluated age and voiding function following POP surgery. 21 One small prospective randomized study evaluated the effect of local estrogen prior to reconstructive vaginal surgery. 22 A case series compared the Le Fort procedure in medically compromised women to pelvic reconstruction in healthier women. 23 Some case series described major comorbidities, postoperative complications, and outcomes, 24,25 including one of POP repair under local anesthesia. 26 Several case series describing technique and results included younger and older women but rarely stratified them by age, and these studies are therefore not reviewed here.

Results

Epidemiology. In one study of older patients receiving routine gynecologic care, 50% to 60% were found to have stage II POP; stage III prolapse was present in 9% of the women aged 60 to 69 and 21% of the women aged 70 and over. 15 A review of long-term-care facility admissions found 25% of the women to have POP, 11% of which was beyond the introitus. 16 Age was found to be an independent risk factor for symptomatic pelvic floor dysfunction (including POP) in a large Australian household survey. 13 A Kaiser database study also found age to be an independent risk factor for pelvic floor surgery. 4 The effect of age was not evaluated in a case-control study of women aged 34 to 75. 17 Other risk factors that have been identified are parity, 4,13,17 body mass index, 4,13 and chronic lung disease or coughing. 4,13 Forceps delivery was found to be a risk factor in an epidemiologic survey, 13 but not a case-control study. 17 There was no difference in POP prevalence with a history of cesarean section or of nonoperative vaginal delivery, 13,17 once the number of vaginal deliveries was controlled for. 17 It must be noted that these studies evaluated the range of younger and older women. No studies evaluated the risk factors just for the older women.

Complications. In one study, 11% of 189 women undergoing POP surgery were found to have mild hydronephrosis and 4% had severe hydronephrosis. 18 Women with hydronephrosis were older (mean age 68 10) than those without (mean age 61 11). However, in multivariable logistic regression, only uterine (rather than anterior vaginal wall) prolapse was found to be statistically associated with hydronephrosis. Age was not associated. Among 323 POP surgical patients at the Cleveland Clinic who had preoperative imaging, 8% were found to have had hydronephrosis--4% mild, 3% moderate, and

230

CHAPTER 9

1% severe. 19 Mean age was 75 in women with and 67 in women without hydronephrosis (P .001). Uterine prolapse was more strongly associated than vaginal vault prolapse with hydronephrosis, even after adjusting for age and degree of prolapse. The two patients with renal insufficiency both had complete procidentia.

Nonsurgical Management. No studies compared types of pessaries. In a case series that preferentially placed Gellhorn pessaries, 96 of 101 women used a Gellhorn. 20 Of five women who could not retain a Gellhorn because of poor perineal support, four used a ring pessary and one a cube. Of 50 patients who continued pessary use 2 months to 5 years, 45 removed and reinserted the pessaries themselves. Forty percent discontinued pessary use because of inadequate symptom relief or inconvenience, but the authors did not further quantify this.

Surgical Management. A retrospective review of 23 women undergoing POP surgery did not find age to correlate with duration of catheterization (independently of estrogen status). 21 Among 43 women who underwent prolapse repair, preoperative vaginal estradiol, compared with placebo, was not found to influence the 3-year relapse rate, although bacteriuria was lower in the immediate postoperative period. 22 Twenty-one medically compromised women who underwent Le Fort procedures, mean age 82 years, and 42 women who had vaginal reconstruction, mean age 67, had a similar number of postoperative complications, including one cardiac arrhythmia and three urinary tract infections in each group. 23 Both groups had 90% to 95% long-term success. In a series of 33 women treated with colpocleises, mean age 78, postoperative complications included congestive heart failure (2) and pneumonia (1). 24 One woman required a second repair. Postoperative complications occurred in 29% of 38 women in another Le Fort procedure case series, including cardiac (11%), respiratory (5%), and urinary (13%) complications. 25 Local anesthesia was used successfully for vaginal POP repair in 20 women, mean age 80 years, including anterior and posterior colporrhaphy, enterocele repair, and Le Fort colpocleisis. 26 The only major complication was venous thrombosis. Pyometra followed a re-do Le Fort colpocleisis in a 92-year-old woman. 27

Summary

Few data exist on the incidence of or risk factors for POP, with the exception of cases that undergo surgery. The benefit of estrogen prior to POP repair, if any, is unknown. Older age, parity, and operative vaginal delivery are risk factors for POP surgery. The risks of pregnancy alone, regardless of route of delivery, or of the number of vaginal deliveries are not clear. In women with POP, age may be a risk factor for the development of hydronephrosis, but uterine procidentia confers the most risk. Pessary management is virtually all by clinical experience, usually passed on by tradition or invented by individual physicians.

Gyn 13 (Level B): Observational studies are needed to define long-term quality-of-life outcomes of nonoperative management of pelvic organ prolapse.

Gyn 14 (Level B): Observational studies are needed to define long-term quality-of-life outcomes of operative management of pelvic organ prolapse.

GERIATRIC GYNECOLOGY

231

Gyn 15 (Level B): Observational studies are needed to determine the patient factors, device factors, and management factors that are associated with successful long-term pessary use.

Gyn 16 (Level B): Pessaries (or other devices) should be developed for use in conservative management of pelvic organ prolapse in women with poor introital support and in whom currently available pessaries are not retained.

Gyn 17 (Level B): Basic science and clinical studies should be performed to delineate the pathophysiology of pelvic organ prolapse, particularly the way that genetic tissue factors confer risk.

Gyn 18 (Level B): Therapies to retard the progression of pelvic organ prolapse by targeting the pathophysiologic tissue factors should be developed.

Gyn 19 (Level B): Long-term observational studies are needed to determine the relative contributions of routes of delivery (cesarean section, operative vaginal, spontaneous vaginal) to the development of pelvic organ prolapse.

Gyn 20 (Level B): Observational studies are needed to determine the condition-specific functional impact of surgery for incontinence and pelvic organ prolapse in elderly women, including sexual function.

Gyn 21 (Level A): Long-term randomized controlled trials are needed to determine whether estrogen use, local or systemic, confers benefit or risk for the progression of pelvic organ prolapse.

Gyn 22 (Level A): Randomized controlled trials are needed to determine whether pre- and postoperative local estrogen therapy improves outcomes of pelvic organ prolapse surgery.

Gyn 23 (Level A): Long-term randomized controlled trials are needed to determine whether selective estrogen receptor modulator use confers benefit or risk for the progression of pelvic organ prolapse.

Gyn 24 (Level C): Randomized controlled trials should be performed to determine whether pessary use in early stages of pelvic organ prolapse retards progression.

Gyn 25 (Levels D, C): Long-term observational trials are needed to obtain indications as to whether pelvic floor muscle exercises retard the progression of pelvic organ prolapse; subsequently, these hypotheses need to be tested through randomized controlled trials.

Gyn 26 (Level D): Longitudinal observational studies are needed to define the natural history of untreated pelvic organ prolapse.

Gyn 27 (Level D): Observational studies are needed to determine the incidence of hydronephrosis in pelvic organ prolapse.

Gyn 28 (Level D): Observational studies are needed to determine modifiable risk factors for pelvic organ prolapse other than childbirth.

232

CHAPTER 9

VULVOVAGINAL CONDITIONS

The nature of atrophic postmenopausal vulvovaginal changes is reasonably well established, but the contributions to these changes of aging, factors common in aging, and hypoestrinism are unclear. The pathophysiology of vaginal and, to a lesser extent, vulvar disorders is a unique combination of hormonal, dermatologic, microbiologic, structural supportive, environmental, neurologic, and psychologic factors. Vulvar pathophysiology is primarily dermatologic, with strong environmental influences and less well understood hormonal components.

The lower vagina, vulva, urethra, and bladder trigone have a common embryologic origin, the urogenital sinus, and are estrogen-responsive tissues. Dermatologic symptoms, vaginal discharge, dyspareunia, irritative voiding symptoms, and urinary tract infections may all be a consequence of prolonged hypoestrinism. Data regarding the prevalence of symptomatic vulvovaginal changes with aging are divergent and difficult to obtain without the inclusion of urologic symptoms such as dysuria, frequency, urgency, and urge incontinence.

Unclear factors associated with aging, hypoestrinism, or local environment increase vulvar susceptibility to dermatologic disorders, including lichen sclerosus, squamous hyperplasia, and neoplasia.

Quality of Studies

Relevant studies of urogenital symptoms include community-based observational surveys 28?32 and a case series of menopause clinic visits. 33 A meta-analysis summarized estrogen therapy trials, 34 an uncontrolled trial evaluated estrogen therapy, 35 and an observational study reported associations with sexual activity. 36 Vulvar cancer data are taken from a population-based study and case series. 37?39 Review articles and one randomized controlled trial are cited regarding vulvar dermatoses and neoplasia. 40?43

Results

Two large surveys gathered data through personal interviews. 28,29 In one, urogenital symptoms were found to be prevalent in 30% of 3000 European women aged 55 to 75. 29 Eleven percent were found to have vaginal itch or burning, of whom 41% had a moderate problem and 17% a severe one. Of women aged 65 to 74, 9% reported having urinary frequency, 6% urinary incontinence, and 4% vaginal burning or itch. Of 2045 British women aged 55 to over 85 years interviewed in their homes, 49% reported having urogenital symptoms some time since menopause, and 31% within the past 2 years. 28 Vaginal itching occurred in 11%, vaginal dryness in 8%, dyspareunia in 2%, and irritative voiding symptoms in 16%. Only 27% were sexually active. Of 900 61-year-old Swedish questionnaire respondents, 38% reported vaginal dryness and dyspareunia, and 15% reported itch, discharge, and "smarting" pain. 32 Among 850 randomly selected postmenopausal Dutch women, 23% reported vaginal itching and 16% dyspareunia. 31 Clinically assessed vulvovaginal atrophy was evident in 34% of women evaluated in a menopause clinic. 33 Approximately 25% of the sexually active women had dyspareunia secondary to vulvovaginal pain.

A meta-analysis of 10 randomized controlled trials and 68 other relevant articles concerning older women, mean ages ranging from 54 to 72, showed that estrogen relieves

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download